Dr. Adam Bass is a professor of medicine in the Division of Hematology and Oncology, founding director of the Center for Precision Cancer Medicine, and director of gastrointestinal oncology at Columbia University Vagelos College of Physicians and Surgeons. He previously served as an assistant professor of medicine at the Harvard Medical School and Dana-Farber Cancer Institute and an associate member of the Broad Institute. Dr. Bass also completed clinical training in internal medicine at the Massachusetts General Hospital and medical oncology training at the Dana-Farber Cancer Institute. He subsequently pursued research training in cancer genomics and cancer biology at both the Dana-Farber Cancer Institute and Broad Institute. He developed a research interest in studying the somatic-genomic alterations in gastrointestinal cancer using new emerging genomic technologies and studying candidate genomic alterations in the laboratory using more traditional functional biology. Since 2010, Dr. Bass has been an independent investigator at the Dana-Farber Cancer Institute, where his laboratory continues to explore the genomic alterations in gastrointestinal cancers, with a special interest in esophageal and gastric cancers. Dr. Bass is also co-chairing The Cancer Genome Atlas (TCGA) studies into gastric and esophageal cancer. Beyond genomic characterization, his laboratory continues to research select oncogenes and tumor suppressors in these tumors and build off the elucidation of genomic alterations to identify new therapeutic vulnerabilities for patients with these diseases.